Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
Central Valley peach growers confront a costly and abrupt pivot after Del Monte closures. About 3,000 acres will be u...
As markets push higher, investors wonder if a downturn is inevitable. This guide dives into history, current signals,...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
If you want income life? here’s a practical plan: three proven dividend growers you can buy today and hold for decade...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...
Uber's CFO argues AI will reduce future hiring needs more than it boosts output, signaling tougher labor-market dynam...
Paladin Power unveiled a non-lithium, solid-state graphene energy storage system that promises safer, faster deployme...
When Ringo Starr performed in San Diego, the night wasn’t just about nostalgia. The All Starr Band’s rotating lineup ...